Seeing Is Believing
NKTR is currently covered by 4 analysts with an average price target of $36.02. This is a potential upside of $-21.75 (-37.65%) from yesterday's end of day stock price of $57.77.
Nektar Therapeutics's activity chart (see below) currently has 21 price targets and 41 ratings on display. The stock rating distribution of NKTR is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 58.8% with an average time for these price targets to be met of 445.26 days.
Highest price target for NKTR is $105, Lowest price target is $6, average price target is $60.
Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 22-Sep-2025. First documented stock forecast 28-Jul-2014.
Currently out of the existing stock ratings of NKTR, 10 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$105
$50.66 (93.23%)
$85
25 days ago
(22-Sep-2025)
0/3 (0%)
$45.4 (76.17%)
Buy
$69
$14.66 (26.98%)
$2
3 months 24 days ago
(23-Jun-2025)
1/3 (33.33%)
$44.55 (182.21%)
295
Buy
$6
$-48.34 (-88.96%)
$5
7 months 4 days ago
(13-Mar-2025)
0/2 (0%)
$-7.5 (-55.56%)
Buy
$4
$-50.34 (-92.64%)
1 years 18 days ago
(29-Sep-2024)
3/4 (75%)
$-15.5 (-79.49%)
645
Sell
1 years 10 months 27 days ago
(20-Nov-2023)
7/8 (87.5%)
$6.02 (54.83%)
509
What is NKTR (Nektar Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on NKTR (Nektar Therapeutics) with a proven track record?
Which analyst has the most public recommendations on NKTR (Nektar Therapeutics)?
Which analyst is the currently most bullish on NKTR (Nektar Therapeutics)?
Which analyst is the currently most reserved on NKTR (Nektar Therapeutics)?